Placeholder Banner

Successful Public-Private Partnerships

October 8, 2013
According to BayBio, biomedical companies that can harness the power of patient groups will get medicines, devices and diagnostics to market faster, cheaper and smarter, helping patients and rewarding investors.

Gail Maderis, ‎President & CEO at BayBio, debuted their preliminary whitepaper entitled "Successful Public-Private Partnerships" today at the 2013 BIO Investor Forum.

BayBio surveyed nearly 100 biotech and foundation CEOs, vice presidents of research, directors of patient advocacy and others across the United States.

Following the release of BayBio’s full national assessment with case studies, a series of focused reports will be issued on key subjects including partnering for funding, patient-driven clinical trial design and recruitment, and regulatory and payor considerations.